Evidence map›Paper›PMID 29875394›Full record

ArticleNature neuroscience2018

Publisher Correction: Mutations in Vps15 perturb neuronal migration in mice and are associated with neurodevelopmental disease in humans.

Thomas Gstrein, Andrew Edwards, Anna Přistoupilová, Ines Leca, Martin Breuss, Sandra Pilat-Carotta, Andi H Hansen, Ratna Tripathy, Anna K Traunbauer, Tobias Hochstoeger and 17 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 7 institutions in 5 countries.

Thomas GstreinInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Andrew EdwardsWellcome Trust Center for Human Genetics (WTCHG), Oxford, UK.
Anna PřistoupilováInstitute of Inherited Metabolic Disorders, Charles University, Prague, Czech Republic.ORCID http://orcid.org/0000-0003-0047-9405
Ines LecaInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Martin BreussInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Sandra Pilat-CarottaInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Andi H HansenInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Ratna TripathyInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Anna K TraunbauerInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Tobias HochstoegerInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Gavril RosoklijaInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Marco RepicInstitute for Molecular Biotechnology (IMBA), Vienna, Austria.
Lukas LandlerInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Viktor StráneckýInstitute of Inherited Metabolic Disorders, Charles University, Prague, Czech Republic.
Gerhard DürnbergerInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Thomas M KeaneWellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.
Johannes ZuberInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
David J AdamsWellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.
Jonathan FlintWellcome Trust Center for Human Genetics (WTCHG), Oxford, UK.
Tomas HonzikDepartment of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Marta GutCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Sergi BeltranCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Karl MechtlerInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Elliott SherrInstitute of Human Genetics, University of California, San Francisco, San Francisco, CA, USA.
Stanislav KmochInstitute of Inherited Metabolic Disorders, Charles University, Prague, Czech Republic.
Ivo GutCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
David A KeaysInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria. keays@imp.ac.at.ORCID http://orcid.org/0000-0002-8343-8002
Research Institute of Molecular Pathology · ATUniversitat Pompeu Fabra · ESCharles University · CZCentre for Human Genetics · GBWellcome Sanger Institute · GBInstitute of Molecular Biotechnology · ATUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the supplementary information PDF originally posted, there were discrepancies from the integrated supplementary information that appeared in the HTML; the former has been corrected as follows. In the legend to Supplementary Fig. 2c, "major organs of the mouse" has been changed to "major organs of the adult mouse." In the legend to Supplementary Fig. 6d,h, "At E14.5 Mbe/Mbe mutants have a smaller percentage of Brdu positive cells in bin 3" has been changed to "At E14.5 Mbe/Mbe mutants have a higher percentage of Brdu positive cells in bin 3."

Identifiers

PMID29875394
OpenAlexW2805445315

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.